Hepatology Communications

Article	Citations
Single‐Cell, Single‐Nucleus, and Spatial RNA Sequencing of the Human Liver Identifies Cholangiocyte and Mesenchymal Heterogeneity	94
Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis	92
Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population	89
Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis	85
Effects of Resmetirom on Noninvasive Endpoints in a 36‐Week Phase 2 Active Treatment Extension Study in Patients With NASH	84
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH	81
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis	72
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression	69
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD	61
Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors	59
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities	59
The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis	58
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection	58
Clinical Features of Patients With COVID‐19 With Nonalcoholic Fatty Liver Disease	55
Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH	53
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States	53
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease	52
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007‐2017	51
Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients	51
Hepatic Stellate Cell Regulation of Liver Regeneration and Repair	49
Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States	48
Human Nonalcoholic Steatohepatitis on a Chip	43
Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis	42
Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials	41
Alcohol‐Associated Liver Disease Before and After COVID‐19—An Overview and Call for Ongoing Investigation	41

Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting	40
Liver Care and Surveillance: The Global Impact of the COVID‐19 Pandemic	39
SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH	39
Impact of COVID‐19 in Liver Disease Progression	38
A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma	38
Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007‐2016	37
Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta‐analysis	37
Genome‐Wide Association Study of NAFLD Using Electronic Health Records	37
Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6	36
Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19	35
Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update	35
Exosome‐Like Nanoparticles From Lactobacillus rhamnosus GG Protect Against Alcohol‐Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice	35
ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice	34
Iron overload disorders	34
Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017–2018 transient elastography data and application of machine learning	34
Reduced Clot Stability by Thromboelastography as a Potential Indicator of Procedure‐Related Bleeding in Decompensated Cirrhosis	34
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes	32
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis	32
Breath Metabolomics Provides an Accurate and Noninvasive Approach for Screening Cirrhosis, Primary, and Secondary Liver Tumors	32
SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination	32
The Impact of COVID‐19 on Organ Donation, Procurement, and Liver Transplantation in the United States	32
Hepcidin Signaling in Health and Disease: Ironing Out the Details	30
Artificial intelligence-based text generators in hepatology: ChatGPT is just the beginning	29
Assessment of the Frail Patient With End‐Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability	29
Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case‐Control Study	28
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol	28
Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis	28
Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis	28
Global and regional long‐term survival following resection for HCC in the recent decade: A meta‐analysis of 110 studies	27
Impact of Obeticholic acid Exposure on Decompensation and Mortality in Primary Biliary Cholangitis and Cirrhosis	27
Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma	27
Fibrosis‐4 Index as an Independent Predictor of Mortality and Liver‐Related Outcomes in NAFLD	27
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients	27
COVID‐19 Aftershocks on Alcohol‐Associated Liver Disease: An Early Cross‐Sectional Report From the U.S. Epicenter	27
Maralixibat for the treatment of PFIC: Long‐term, IBAT inhibition in an open‐label, Phase 2 study	26
Impacts of Early Kasai Portoenterostomy on Short‐Term and Long‐Term Outcomes of Biliary Atresia	26
Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis	26
Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity	26
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID‐19 Infection	25
The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007‐2017	25
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance	24
CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma	24
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population‐Based Study in Germany	24
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes	24
A Dynamic Aspartate‐to‐Alanine Aminotransferase Ratio Provides Valid Predictions of Incident Severe Liver Disease	23
Associations Between Alcohol Use and Liver‐Related Outcomes in a Large National Cohort of Patients With Cirrhosis	23
Tinospora Cordifolia (Giloy)–Induced Liver Injury During the COVID‐19 Pandemic—Multicenter Nationwide Study From India	23
Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice	23
Transcriptomic Cross‐Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and Mice	23
Single‐cell transcriptomics reveals conserved cell identities and fibrogenic phenotypes in zebrafish and human liver	23

Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data	23
Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD	22
Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort	22
Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis	22
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma Progression	22
Gamma‐Glutamyltransferase Elevation Is Frequent in Patients With COVID‐19: A Clinical Epidemiologic Study	22
Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity	22
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma	22
Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis	22
Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient	22
Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation	21
Immune‐mediated liver injury following COVID‐19 vaccination: A systematic review	21
Genome‐Wide Association Study of Liver Fat: The Multiethnic Cohort Adiposity Phenotype Study	21
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study	21
Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co‐Metabolism in Patients With Alcoholic Hepatitis	21
ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation	21
Urgent Liver Transplantation Soon After Recovery From COVID‐19 in a Patient With Decompensated Liver Cirrhosis	21
Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B	21
Exploratory Study of Autoantibody Profiling in Drug‐Induced Liver Injury with an Autoimmune Phenotype	20
Developmental Programming of NAFLD by Parental Obesity	20
Hepatic NF‐κB‐Inducing Kinase and Inhibitor of NF‐κB Kinase Subunit α Promote Liver Oxidative Stress, Ferroptosis, and Liver Injury	20
Hepatocyte TGF‐β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let‐7b‐5p	20
Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests	20
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease	20
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies	19
The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis	19
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study	19
Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth	19
Innovations in Hepatitis C Screening and Treatment	19
Intratumoral Microbiome of Human Primary Liver Cancer	19
Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020	19
Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity	19
Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments	18
Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5‐year follow‐up study	18
Functionally Diverse Inflammatory Responses in Peripheral and Liver Monocytes in Alcohol‐Associated Hepatitis	18
Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma	18
Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population‐Based Study of Mexican Americans	18
Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma	18
Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis	17
Cluster of Differentiation 44 Promotes Liver Fibrosis and Serves as a Biomarker in Congestive Hepatopathy	17
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease	17
Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα‐FGF21 Axis	17
What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?	17
Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease	17
Integrin subunit beta 8 contributes to lenvatinib resistance in HCC	17
Intestinal virome in patients with alcohol use disorder and after abstinence	17
COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality	17
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC	17
Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019	16
Loss of c‐Jun N‐terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma	16
Impact of Sodium Glucose Cotransporter 2 Inhibitors on Nonalcoholic Fatty Liver Disease Complicated by Diabetes Mellitus	16
Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trial	16
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis	16
ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma	16
Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B	16
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways thro	16
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta	16
High‐Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer’s Disease	16
Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell–Mediated Antitumor Immunity Through PD‐L1	16
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB	16
Correlation Between Clinical and Pathological Findings of Liver Injury in 27 Patients With Lethal COVID‐19 Infections in Brazil	16
Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon‐α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus	16
The Exosome‐Associated Tetraspanin CD63 Contributes to the Efficient Assembly and Infectivity of the Hepatitis B Virus	16
Setting up criteria for drug‐induced autoimmune‐like hepatitis through a systematic analysis of published reports	16
Genome‐Wide Association Study of Lean Nonalcoholic Fatty Liver Disease Suggests Human Leukocyte Antigen as a Novel Candidate Locus	16
Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID‐19	15
Ultrasensitive Assay for Hepatitis B Core‐Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir	15
Clinical phenotype of adult‐onset liver disease in patients with variants in ABCB4 , ABCB11 , and ATP8B1	15
Sarcopenia, healthy living, and mortality in patients with chronic liver diseases	15
Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease	15
Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis	15
Heterozygosity of the Alpha 1‐Antitrypsin Pi*Z Allele and Risk of Liver Disease	15
Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis	15
Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease	15
Improving Medication‐Related Outcomes in Chronic Liver Disease	14
Growth hormone deficiency and NAFLD: An overlooked and underrecognized link	14
Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease	14
Clinical Staging of Mass‐Forming Intrahepatic Cholangiocarcinoma: Computed Tomography Versus Magnetic Resonance Imaging	14
Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species	14
Linoleic Acid‐Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol‐Associated Liver Injury	14

PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga	14
Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes	14
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis	14
Loss of Coordinated Neutrophil Responses to the Human Fungal Pathogen, Candida albicans, in Patients With Cirrhosis	14
Primary biliary cholangitis: Epidemiology, prognosis, and treatment	14
Burden of Cirrhosis on Patients and Caregivers	14
#LiverTwitter: An Emerging Tool for Liver Education and Research	13
Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis	13
The burden of liver cirrhosis and underlying etiologies: results from the Global Burden of Disease Study 2019	13
COVID‐19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action	13
STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes	13
Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C	13
Efficient silencing of hepatitis B virus S gene through CRISPR‐mediated base editing	13
The Natural History of NAFLD, a Community‐Based Study at a Large Health Care Delivery System in the United States	13
High reproducibility of spleen stiffness measurement by vibration‐controlled transient elastography with a spleen‐dedicated module	13
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis	13
Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China	13
Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus	13
Transcriptional Analysis of Liver Tissue Identifies Distinct Phenotypes of Indeterminate Pediatric Acute Liver Failure	13
Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations	13
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents	12
Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial	12
National Early Career Transplant Hepatologist Survey: Compensation, Burnout, and Job Satisfaction	12
Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD	12
Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other Hispanics	12
The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity	12
Secular Trends and Geographic Maps of Hepatitis C Virus Infection among 4 Million Blood Donors in Taiwan from 1999 to 2017	12
Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo‐Independent Regulation of Heat Shock Protein 70 Family Members	12
The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis	12
Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease	12
Development of Alcohol‐Associated Hepatitis Is Associated With Specific Changes in Gut‐Modified Bile Acids	12
Molecular Profiling of Decompensated Cirrhosis by a Novel MicroRNA Signature	12
Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD	12
Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis	12
Cellular Location of HNF4α is Linked With Terminal Liver Failure in Humans	12
Perceptions of Exercise and Its Challenges in Patients With Nonalcoholic Fatty Liver Disease: A Survey‐Based Study	12
Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses	12
Interferon Type I Regulates Inflammasome Activation and High Mobility Group Box 1 Translocation in Hepatocytes During Ehrlichia‐Induced Acute Liver Injury	12
Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017–2018	12
Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model	12
Automated Measurements of Body Composition in Abdominal CT Scans Using Artificial Intelligence Can Predict Mortality in Patients With Cirrhosis	12
An RNA Interference/Adeno‐Associated Virus Vector–Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus	12
A Population‐Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection	11
Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis	11
Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt	11
Hepatic retinoic acid receptor alpha mediates all‐trans retinoic acid's effect on diet‐induced hepatosteatosis	11
Cognitive Impairment and Physical Frailty in Patients With Cirrhosis	11
Cooperation Between the NRF2 Pathway and Oncogenic β‐catenin During HCC Tumorigenesis	11
Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome	11
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure	11
RORα Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes	11
Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age	11
An Experimental DUAL Model of Advanced Liver Damage	11
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature	11
Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol‐Associated Liver Disease	11
Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation	11
Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community‐Based Sample of Mexican‐Origin Adults	11
Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis	11
Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy	11
Health‐Related Quality of Life and Its Contributors According to a Preference‐Based Generic Instrument in Cirrhosis	11
Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care	11
Early Allograft Dysfunction Increases Hospital Associated Costs After Liver Transplantation—A Propensity Score–Matched Analysis	11
Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice	11
Validation of a Simple Quality‐of‐Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy	11
Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis	11
Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response	11
Associations between six dietary habits and risk of hepatocellular carcinoma: A Mendelian randomization study	11
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019	11
The Matrisome Genes From Hepatitis B–Related Hepatocellular Carcinoma Unveiled	10
Prognostic Value of the CLIF‐C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt	10
Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis	10
Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex	10
High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases	10
High Effectiveness of Broad Access Direct‐Acting Antiviral Therapy for Hepatitis C in an Australian Real‐World Cohort: The REACH‐C Study	10
Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute‐On‐Chronic Liver Failure	10
Developing Priorities for Palliative Care Research in Advanced Liver Disease: A Multidisciplinary Approach	10
Body fat composition determines outcomes before and after liver transplantation in patients with cirrhosis	10
Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort	10
Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals	10
Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy	10
NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population	10
Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome	10
Hepatitis C is associated with more adverse pregnancy outcomes than hepatitis B: A 7‐year national inpatient sample study	10
Bleeding Outcomes Following Transesophageal Echocardiography in Patients With Cirrhosis and Esophageal Varices	10
Detection of Hepatitis B Virus–Host Junction Sequences in Urine of Infected Patients	10
The unfolded protein response to PI*Z alpha‐1 antitrypsin in human hepatocellular and murine models	10
A Telephone and Mail Outreach Program Successfully Increases Uptake of Hepatocellular Carcinoma Surveillance	10
Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study	10
A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer	10
Short‐Term Safety of Repeated Acetaminophen Use in Patients With Compensated Cirrhosis	10
Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA	10
Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin	10
Tissue‐Specific Regulation of Ferroportin in Wild‐Type and Hjv‐/‐ Mice Following Dietary Iron Manipulations	10
Male‐Specific Activation of Lysine Demethylases 5B and 5C Mediates Alcohol‐Induced Liver Injury and Hepatocyte Dedifferentiation	10
Alcohol‐associated fibrosis in females is mediated by female‐specific activation of lysine demethylases KDM5B and KDM5C	10